HDAC5 and breast cancer: (113) selected a series of HDACis including SAHA, TSA, LBH-589, PXD-101, MS-275, MC-1568, Romidepsin and Sulforaphane (SFN) to test their inhibitory effect towards HDAC5 expression on breast cancer cells.